VAERS 2709192
SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ784AB
- Staat
- OR
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 03.11.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Symptomtext
expired ACT HIB vaccine was administered to patient with no reported adverse event; Initial information received on 17-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old male patient who was administered an expired Hib (Prp/T) Vaccine [Act-Hib] was administered to patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis a vaccine (hepatitis a) for immunisation; measles vaccine, mumps vaccine, rubella vaccine (mmr) for immunisation; and varicella zoster vaccine (varicella vaccine) for immunisation. On 16-Oct-2023, the patient received 0.5 ml (Dose 4) of suspect HIB (PRP/T) VACCINE Powder and solvent for solution for injection (lot number: UJ784AB, Expiry date: 08-Oct-2023) (Strength: standard) (Frequency: once) via unknown route in unknown administration site for immunization. On 16-Oct-2023 the patient was administered an expired Hib (Prp/T) Vaccine [Act-Hib] was administered to patient with no reported adverse event (expired product administered) (latency: same day). It was reported, Compliance Specialist called from doctor`s office where an expired ACT HIB vaccine was administered to patient. This inquiry was submitted since an expired dose was given to a patient. Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A; MMR; VARICELLA VACCINE
- Allergien
- -
- Vorherige Impfungen
- -